A global investment group invests through multiple vehicles and has over $1B targeted on healthcare and life science under management. The firm recently launched a new vehicle to invest in digital health technologies. The group will invest $0.5-1M, mainly in seed-series A companies developing software-based digital technologies.
The firm is interested in software-based digital health companies. The group will not invest in wearables or smart devices. The firm invests primarily in B2B or B2B2C companies, and looks for technologies that have clear cost saving or revenue generating aspect for clients. While the firm will invest globally, they are looking for companies targeting the US market.
The firm is a very active investor, leveraging their network and broad-cross sector activity to help their portfolio companies. The group is looking for companies that, at minimum, have a viable understanding of the US healthcare market.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment